What are the criteria for performing ultrasound on a lymph node?

Criteria for Performing Ultrasound on a Lymph Node

Ultrasound should be performed on lymph nodes when they meet size criteria (long axis >1.5 cm or short axis >1.0 cm if long axis is 1.1-1.5 cm) OR when they demonstrate suspicious ultrasonographic features regardless of size, including round shape, distinct margins, heterogeneous echogenicity, loss of fatty hilum, peripheral/mixed vascularization, microcalcifications, or cystic changes.

Size-Based Criteria

The most widely accepted size thresholds for considering a lymph node abnormal and warranting ultrasound evaluation are 1:

• Long axis >1.5 cm (regardless of short axis measurement)
• Long axis 1.1-1.5 cm AND short axis >1.0 cm
• Lymph nodes measuring ≤1.0 x 1.0 cm are generally not considered abnormal

However, size alone is an unreliable predictor of malignancy 2. Multiple studies show conflicting results regarding size as a criterion, with some finding no significant correlation between size and malignancy risk when using dichotomous cutoffs 3.

Suspicious Ultrasonographic Features (Major Criteria)

These four features independently predict malignancy and warrant ultrasound evaluation and biopsy 2:

1. Microcalcifications/hyperechoic punctuations - Specificity 100%, though sensitivity only 11-46% 4
2. Cystic appearance - Specificity 100%, sensitivity 11% 4
3. Peripheral and/or mixed vascularization - Best sensitivity-specificity compromise (86% sensitivity, 82% specificity) 4. Increased vascularity with >4 vessels has 87.7% sensitivity and 69.6% specificity 2
4. Loss of fatty hyperechoic hilum - Sensitivity 100% but specificity only 29% 4

Additional Suspicious Features

These features are less specific individually but support the decision for ultrasound when combined 2:

• Round shape (long-to-short axis ratio <2) - More predictive of malignancy than oval/triangular shapes
• Distinct/sharp margins - Independently predictive in multivariate analysis
• Heterogeneous echogenicity - Independently predictive of malignancy
• Central necrosis sign

Context-Specific Indications

Thyroid Cancer Follow-up

Ultrasound is indicated 5, 6:

• 6-12 months post-surgery for all patients
• When thyroglobulin levels rise during follow-up
• For lymph nodes ≥5-7 mm with at least two ultrasound criteria of malignancy
• Do not routinely biopsy nodes <5-7 mm unless serum markers are elevated

Lung Cancer Staging

Ultrasound of supraclavicular lymph nodes is indicated 7:

• Short axis ≥5 mm with rounded shape and missing echogenic hilum
• Particularly in patients with CT stage N2/N3 or extensive disease
• US has higher sensitivity than CT for detecting pathological lymph nodes

Melanoma Surveillance

Ultrasound is superior to palpation and should be performed when nodes demonstrate 8:

• Circular or oval hypoechoic appearance
• Lack of hyperechoic hila
• These stringent criteria provide 76.9% sensitivity and 98.4% specificity

Benign Features (Ultrasound NOT Indicated)

Lymph nodes with these features can be observed without immediate ultrasound-guided biopsy 2, 4:

• Presence of hyperechoic hilum (highly predictive of benignity)
• Central hilar vascularization only (single central vessel, no peripheral flow)
• Homogeneous echogenicity with germinal center
• Oval/triangular shape with L/S ratio ≥2

When all four major suspicious features are absent, 96% of lymph nodes are benign 2.

Critical Caveat

Ultrasonographic features alone are not reliable enough to forgo biopsy 2. While ultrasound can guide sampling priorities, tissue diagnosis remains essential for definitive diagnosis. The combination of suspicious ultrasound features should prompt ultrasound-guided fine needle aspiration or core biopsy, which has superior diagnostic accuracy compared to imaging alone 9, 10.

For thyroid cancer specifically, thyroglobulin testing on needle washout fluid should accompany any lymph node biopsy 6.